Latest Alzheimer's news
FDA Approves Subcutaneous Leqembi for Treatment of Early Alzheimer Disease
posted September 2nd
by modernClinician Editorial Team
by modernClinician Editorial Team
Mediterranean Diet Beneficial in Those With High Alzheimer Disease Risk
posted August 28th
by modernClinician Editorial Team
by modernClinician Editorial Team
Lifestyle Interventions Improve Cognition for At-Risk Older Adults
posted July 30th
by modernClinician Editorial Team
by modernClinician Editorial Team
GLP-1 Receptor Agonists Tied to Decrease in T2DM-Related Dementia Risk
posted July 23rd
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
Cortical Atrophy in Early-Onset Alzheimer Disease Signature Can Predict Progression to Dementia 
Exercise Link to Dementia Varies by Physical Activity Domain 
Real-World ARIA Incidence With Lecanemab Aligns With Clinical Trial Findings Related Articles
Many With Atypical Alzheimer Disease Do Not Qualify for Anti-Amyloid Therapy 
Menopausal Hormone Therapy Use Linked to Lower Risk for Alzheimer Disease 
Subclinical Cardiac Dysfunction Linked to Neurodegeneration in APOE-ε4 Carriers 
Sugar Restriction in First 1,000 Days From Conception Linked to Lower Risk for Dementia Monthly Specialist Briefings
Stay Connected
